The approval follows the successful completion of its 56,000m2 state-of-the-art production site in Corinth, Greece.
The FDA's interest in the treatment as a potential therapy for sleep apnoea is "extremely encouraging".
The study provides evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression.
The organisation is aiming to support the expanding patient community with the clinic’s opening.
MGC Pharma has carried out a clinical trial with its Cognican formula - an oral spray containing THC and CBD.
The company has announced that it has obtained a production license for medical cannabis products in the country.
The state-of-the-art facility is now readying for the first delivery of medical grade cannabis for German patients.
The company has signed a distribution agreement with Sana Life Sciences.
Emerald Health Therapeutics has signed an agreement with Skye Bioscience.
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and...